This page shows you your search results in order of relevance.

Order by Relevance | Date

Total 4794145 results found since Jan 2013.

Use of Telemedicine Technologies in the Management of Infectious Diseases: A Review
Telemedicine technologies are rapidly being integrated into infectious diseases programs with the aim of increasing access to infectious diseases specialty care for isolated populations and reducing costs. We summarize the utility and effectiveness of telemedicine in the evaluation and treatment of infectious diseases patients. The use of telemedicine in the management of acute infectious diseases, chronic hepatitis C, human immunodeficiency virus, and active pulmonary tuberculosis is considered. We recapitulate and evaluate the advantages of telemedicine described in other studies, present challenges to adopting telemedic...
Source: Clinical Infectious Diseases - March 12, 2015 Category: Infectious Diseases Authors: Parmar, P., Mackie, D., Varghese, S., Cooper, C. Tags: CLINICAL PRACTICE Source Type: research

Maintaining Life-saving Testing for Patients With Infectious Diseases: Infectious Diseases Society of America, American Society for Microbiology, and Pan American Society for Clinical Virology Recommendations on the Regulation of Laboratory-developed Tests
In 2014, the US Food and Drug Administration (FDA) proposed to regulate laboratory-developed tests (LDTs)—diagnostics designed, manufactured, and used within a single laboratory. The Infectious Diseases Society of America, the American Society for Microbiology, and the Pan American Society for Clinical Virology recognize that the FDA is committed to protecting patients. However, our societies are concerned that the proposed regulations will limit access to testing and negatively impact infectious diseases (ID) LDTs. In this joint commentary, our societies discuss why LDTs are critical for ID patient care, hospital in...
Source: Clinical Infectious Diseases - June 29, 2016 Category: Infectious Diseases Authors: Caliendo, A. M., Couturier, M. R., Ginocchio, C. C., Hanson, K. E., Miller, M. B., Walker, K. E., Frank, G. M., for the Infectious Diseases Society of America; the American Society for Microbiology; and the Pan-American Society for Clinical Virology Tags: IDSA PUBLIC POLICY Source Type: research

Review of Twitter for Infectious Diseases Clinicians: Useful or a Waste of Time?
Twitter is a social networking service that has emerged as a valuable tool for healthcare professionals (HCPs). It is the only platform that allows one to connect, engage, learn, and educate oneself and others in real time on a global scale. HCPs are using social media tools to communicate, educate, and engage with their peers worldwide. Twitter allows HCPs to deliver easily accessible "real-time" clinical information on a global scale. Twitter has more than 500 million active users who generate more than 58 million tweets and 2.1 billion search queries every day. Here, we explain why Twitter is important, how and when an ...
Source: Clinical Infectious Diseases - April 28, 2015 Category: Infectious Diseases Authors: Goff, D. A., Kullar, R., Newland, J. G. Tags: CLINICAL PRACTICE Source Type: research

Epidemiology and Outcome of Fungemia in a Cancer Cohort of the Infectious Diseases Group (IDG) of the European Organization for Research and Treatment of Cancer (EORTC 65031)
Conclusions. Fungemia, mostly due to Candida spp., was rare in cancer patients from EORTC centers but was associated with substantial mortality. Antifungal prophylaxis and remission of cancer predicted better survival.
Source: Clinical Infectious Diseases - July 15, 2015 Category: Infectious Diseases Authors: Cornely, O. A., Gachot, B., Akan, H., Bassetti, M., Uzun, O., Kibbler, C., Marchetti, O., de Burghgraeve, P., Ramadan, S., Pylkkanen, L., Ameye, L., Paesmans, M., Donnelly, P. J., on behalf of the EORTC Infectious Diseases Group, on behalf of the EORTC In Tags: ARTICLES AND COMMENTARIES Source Type: research

Predictions for the Field of Infectious Diseases for 2015Predictions for the Field of Infectious Diseases for 2015
John Bartlett admits that predictions are dangerous and there will be surprises, yet he forges ahead with his best guesses for what will make headlines in the field of infectious diseases this year. Medscape Infectious Diseases
Source: Medscape Infectious Diseases Headlines - January 30, 2015 Category: Infectious Diseases Tags: Infectious Diseases Article Source Type: news

Landmark Developments in Infectious DiseasesLandmark Developments in Infectious Diseases
The field of infectious diseases has made huge strides, but human behavior has at times impeded this progress. Medscape Infectious Diseases
Source: Medscape Infectious Diseases Headlines - October 20, 2015 Category: Infectious Diseases Tags: Infectious Diseases Article Source Type: news

Infectious Diseases Outlook for 2016Infectious Diseases Outlook for 2016
John Bartlett outlines the most important infectious diseases problems facing the country today. Medscape Infectious Diseases
Source: Medscape Infectious Diseases Headlines - May 10, 2016 Category: Infectious Diseases Tags: Infectious Diseases Article Source Type: news

Swiss Society for Infectious Diseases/International Society for Infectious Diseases Fellowships
The objectives of the Fellowship Program are: • to train promising young physicians and scientists from developing and middle income countries for clinical and research positions in infectious diseases • to foster partnerships between Fellows and infectious disease leaders in Switzerland • to increase scientific research capacity in low income/high disease burden countries Opportunities for training and research in a variety of areas ranging from basic studies of the mechanism of disease to studies in public health, epidemiology, diagnostics, therapeutics or vaccine development, are available through...
Source: ScanGrants feed - November 11, 2013 Category: Research Authors: Swiss Society for Infectious Diseases/International Society for Infectious Diseases Source Type: funding

Merck Announces Publication of Pivotal Data from Phase 3 Clinical Studies of ZERBAXA™ (Ceftolozane/Tazobactam) in The Lancet and Clinical Infectious Diseases
Dateline City: KENILWORTH, N.J. KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that The Lancet and Clinical Infectious Diseases have published online the results from the pivotal Phase 3 clinical studies of ZERBAXA™ (ceftolozane/tazobactam) for Injection (1 g/0.5 g) in complicated urinary tract infections (cUTI) and complicated intra-abdominal infections (cIAI), respectively. The results will also appear in forthcoming print issues of the journals. Language: English ...
Source: Merck.com - Corporate News - April 27, 2015 Category: Pharmaceuticals Tags: Corporate News Latest News Source Type: news

Assessment of Congenital Anomalies in Infants Born to Pregnant Women Enrolled in Clinical Trials
In 2011 and 2012, the Division of Microbiology and Infectious Diseases at the National Institute of Allergy and Infectious Diseases, National Institutes of Health, held a series of meetings to provide guidance to investigators regarding study design of clinical trials of vaccines and antimicrobial medications that enroll pregnant women. Assessment of congenital anomalies among infants born to women enrolled in these trials was recognized as a challenging issue, and a workgroup with expertise in epidemiology, pediatrics, genetics, dysmorphology, clinical trials, and infectious diseases was formed to address this issue. The ...
Source: Clinical Infectious Diseases - November 25, 2014 Category: Infectious Diseases Authors: Rasmussen, S. A., Hernandez-Diaz, S., Abdul-Rahman, O. A., Sahin, L., Petrie, C. R., Keppler-Noreuil, K. M., Frey, S. E., Mason, R. M., Nesin, M., Carey, J. C. Tags: INCLUDING PREGNANT WOMEN IN CLINICAL TRIALS OF ANTIMICROBIALS AND VACCINES Source Type: research

A systems biology approach for diagnostic and vaccine antigen discovery in tropical infectious diseases
Purpose of review: There is a need for improved diagnosis and for more rapidly assessing the presence, prevalence, and spread of newly emerging or reemerging infectious diseases. An approach to the pathogen-detection strategy is based on analyzing host immune response to the infection. This review focuses on a protein microarray approach for this purpose. Recent findings: Here we take a protein microarray approach to profile the humoral immune response to numerous infectious agents, and to identify the complete antibody repertoire associated with each disease. The results of these studies lead to the identification of diag...
Source: Current Opinion in Infectious Diseases - August 29, 2015 Category: Infectious Diseases Tags: TROPICAL AND TRAVEL-ASSOCIATED DISEASES: Edited by Joseph M. Vinetz and Yukari C. Manabe Source Type: research

Infectious Diseases Society of America Position Statement on Telehealth and Telemedicine as Applied to the Practice of Infectious Diseases
The use of telehealth and telemedicine offers powerful tools for delivering clinical care, conducting medical research, and enhancing access to infectious diseases physicians. The Infectious Diseases Society of America (IDSA) has prepared a position statement to educate members on the use of telehealth and telemedicine technologies. The development of telehealth and telemedicine programs requires the consideration of several issues such as HIPAA, state and local licensure requirements, credentialing and privileging, scope of care, quality, and responsibility and liability. IDSA supports appropriate use of telehealth and te...
Source: Clinical Infectious Diseases - January 16, 2017 Category: Infectious Diseases Authors: Siddiqui, J., Herchline, T., Kahlon, S., Moyer, K. J., Scott, J. D., Wood, B. R., Young, J. Tags: IDSA Public Policy Source Type: research

The Relationship Between Performance on the Infectious Diseases In-Training and Certification Examinations
Conclusions. The significant relationship between the IDSA ITE score and performance on the ABIM Infectious Disease Certification Examination supports the use of the ITE as a valid feedback tool in fellowship training.
Source: Clinical Infectious Diseases - February 16, 2015 Category: Infectious Diseases Authors: Grabovsky, I., Hess, B. J., Haist, S. A., Lipner, R. S., Hawley, J. L., Woodward, S., Engleberg, N. C. Tags: ARTICLES AND COMMENTARIES Source Type: research

Infectious Diseases Subspecialty: Declining Demand Challenges and Opportunities
We present potential solutions to this problem of declining interest in the field of infectious diseases.
Source: Clinical Infectious Diseases - November 11, 2014 Category: Infectious Diseases Authors: Chandrasekar, P., Havlichek, D., Johnson, L. B. Tags: VIEWPOINTS Source Type: research

The Infectious Diseases Physician in the Future of Healthcare: Not Only About Antibiotic Prescribing
The uncertainties of healthcare payment and delivery reform on income and care process have created a sense of foreboding, concern, and fear that a career in medicine is not what it used to be and that a career in infectious diseases in particular may no longer be viable. Fears have been raised that the need for infectious diseases consultation and management will be curtailed because we provide cognitive services that are not perceived as being needed in a health system filled with intensivists, hospitalists, and skilled nursing facility physicians. Now is the time for us to reframe our role in the health system that is e...
Source: Clinical Infectious Diseases - February 16, 2015 Category: Infectious Diseases Authors: Nahass, R. G. Tags: VIEWPOINTS Source Type: research